NewsRx

Search our medical news database

Genetics

DNA Sequencing Mutation Studies Announced

Published in Gene Therapy Weekly, March 24th, 1997

Lark Technologies Inc., Houston, Texas, announced the initiation of mutation detection studies in its senescence gene research program.

Lark's senescence gene research program has moved to a new phase with direct testing of tumor derived cell lines to identify potential mutations in its previously announced candidate senescence gene linked to cellular aging and cancer. The research helps identify the types of mutations in the gene which could contribute to cell immortalization, a prerequisite of cancer.

Previous research has firmly established that four genetic pathways, known as Complementation Groups A, B, C, and D work together to prevent cell...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now


Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Gene Therapy Weekly


NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook